Cognition Therapeutics Income Statement (2020-2026) | CGTX

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
3.67M6.52M8.27M5.43M8.50M11.67M11.60M10.55M11.58M11.39M8.15M10.79M11.48M3.77M11.15M6.12M
Selling, General & Administrative (Quarter)
1.55M2.90M4.36M3.54M3.32M3.08M3.59M3.55M3.10M3.07M2.57M2.99M2.50M2.60M2.52M2.70M
Other Operating Expenses (Quarter)
-10.57M-14.00M
Operating Expenses (Quarter)
5.22M9.41M12.62M8.97M11.82M14.74M15.19M14.10M14.68M14.46M0.15M13.78M13.98M6.38M-0.33M8.82M
Operating Income (Quarter)
-5.22M-11.81M-9.41M-12.62M-9.30M-8.97M-11.82M-14.74M-15.19M-14.10M-14.68M-14.46M-10.72M-13.78M-13.98M-6.38M-13.67M-8.82M
EBIT (Quarter)
-1.49M-5.22M-11.81M-9.41M-5.88M-12.62M-9.30M-8.97M-11.82M-14.74M-15.19M-14.10M-14.68M-14.46M-10.72M-13.78M-13.98M-6.38M-13.67M-8.82M
Non-operating items
Interest & Investment Income (Quarter)
-0.01M-0.00M-0.01M-0.01M-0.01M-0.00M-0.01M-0.01M-0.00M-0.01M-0.01M
Other Non Operating Income (Quarter)
2.11M4.47M5.70M6.00M4.12M2.80M7.09M8.00M7.05M4.95M7.64M4.53M2.88M5.29M7.24M1.45M10.33M4.25M
Non Operating Income (Quarter)
2.11M4.47M5.70M6.00M4.12M2.80M7.09M8.00M7.05M4.95M7.64M4.53M2.88M5.29M7.24M1.45M10.33M4.25M
Net income details
EBT (Quarter)
-1.49M-5.22M-11.81M-3.71M-5.88M-12.62M-9.30M-6.17M-4.73M-14.75M-15.20M-14.11M-14.69M-14.47M-10.73M-13.78M-13.98M-6.38M-13.68M-8.82M
Tax Provisions (Quarter)
0.12M-0.12M
Profit After Tax (Quarter)
-1.49M-3.11M-7.34M-3.84M-5.75M-6.62M-5.18M-6.17M-4.73M-6.75M-8.14M-9.15M-7.04M-9.94M-7.84M-8.48M-6.73M-4.93M-3.34M-8.82M
Income from Continuing Operations (Quarter)
-1.49M-5.22M-11.81M-3.84M-5.75M-12.62M-9.30M-6.17M-4.73M-14.75M-15.20M-14.11M-14.69M-14.47M-10.73M-13.78M-13.98M-6.38M-13.68M-8.82M
Consolidated Net Income (Quarter)
-1.49M-5.22M-11.81M-3.84M-5.75M-12.62M-9.30M-6.17M-4.73M-14.75M-15.20M-14.11M-14.69M-14.47M-10.73M-13.78M-13.98M-6.38M-13.68M-8.82M
Income towards Parent Company (Quarter)
-1.49M-5.22M-11.81M-3.84M-5.75M-12.62M-9.30M-6.17M-4.73M-14.75M-15.20M-14.11M-14.69M-14.47M-10.73M-13.78M-13.98M-6.38M-13.68M-8.82M
Preferred Dividend Payments (Quarter)
1.86M
Net Income towards Common Stockholders (Quarter)
-1.49M-4.97M-11.81M-3.84M-5.75M-6.62M-9.30M-6.17M-4.73M-14.75M-15.20M-14.11M-14.69M-14.47M-10.73M-13.78M-13.98M-6.38M-13.68M-8.82M
Additional items
EPS (Basic) (Quarter)
-4.77-8.1211.74-0.17-0.25-0.29-0.20-0.21-0.16-0.22-0.27-0.27-0.18-0.25-0.17-0.14-0.11-0.06-0.02-0.05
EPS (Weighted Average and Diluted) (Quarter)
-4.77-8.1211.74-0.17-0.25-0.29-0.20-0.21-0.16-0.22-0.27-0.27-0.18-0.25-0.17-0.14-0.11-0.06-0.02-0.05
Shares Outstanding (Weighted Average) (Quarter)
0.57M0.59M5.19M22.43M22.51M23.02M23.64M29.09M29.36M30.37M30.03M33.74M40.06M38.08M39.73M61.83M62.17M0.51M0.51M0.51M
Shares Outstanding (Diluted Average) (Quarter)
0.59M0.59M5.19M22.43M22.51M23.02M23.64M29.09M29.61M29.70M30.03M33.74M40.06M38.08M39.73M61.83M63.69M77.95M72.77M89.19M
EBITDA (Quarter)
-1.49M-3.11M-7.34M-3.84M-5.75M-6.63M-5.18M-6.17M-4.73M-6.75M-8.14M-8.96M-7.04M-9.94M-7.84M-8.48M-6.73M-4.93M-3.34M-4.57M
Shares Outstanding (Quarter)
0.61M0.62M22.23M22.58M22.60M23.97M28.99M29.28M30.29M30.42M32.17M39.99M40.11M40.81M59.85M61.97M64.96M88.27M88.90M89.35M
Tax Rate (Quarter)
-3.372.13